Assertio Therapeutics Announces Sale of NUCYNTA Franchise to Collegium Pharmaceutical for $375.0 Million Read more
Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science Read more
ReAlta Life Sciences Announces FDA Orphan Drug Designation for PIC1 for the Treatment of Hypoxic-Ischemic Encephalopathy Read more